Stay updated on ELiSA Study: Lixivaptan in ADPKD Clinical Trial

Sign up to get notified when there's something new on the ELiSA Study: Lixivaptan in ADPKD Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ELiSA Study: Lixivaptan in ADPKD Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    New Revision: v3.3.3 appears in the record history. The footer/history no longer shows 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2'.
    Difference
    0.2%
    Check dated 2025-12-23T08:48:55.000Z thumbnail image
  3. Check
    22 days ago
    No Change Detected
  4. Check
    29 days ago
    No Change Detected
  5. Check
    36 days ago
    Change Detected
    Summary
    The revision label changed from v3.3.1 to v3.3.2, and no study data, statuses, or contact information appears altered; to avoid alerts from small changes, set an alert condition.
    Difference
    0.1%
    Check dated 2025-12-01T16:54:39.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    The Record History now includes a new revision entry (v3.3.1) and removes the previous entry (v3.2.0).
    Difference
    0.1%
    Check dated 2025-11-24T14:35:23.000Z thumbnail image
  7. Check
    51 days ago
    Change Detected
    Summary
    The government funding status notice banner was removed from the page, which does not affect study details or navigation. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2025-11-17T06:51:08.000Z thumbnail image
  8. Check
    65 days ago
    Change Detected
    Summary
    No substantive content changes are observed; the history page layout remains the same with only minor visual spacing differences. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-03T01:17:43.000Z thumbnail image
  9. Check
    93 days ago
    Change Detected
    Summary
    Summary: The page adds a government-operating-status notice and a v3.2.0 release tag, while removing the v3.1.0 tag. The new notice is the significant change, signaling updated operating status and potential transaction delays.
    Difference
    11%
    Check dated 2025-10-05T10:16:20.000Z thumbnail image

Stay in the know with updates to ELiSA Study: Lixivaptan in ADPKD Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ELiSA Study: Lixivaptan in ADPKD Clinical Trial page.